We are live on ! Find out more
HLF icon

Herbalife

215 hedge funds and large institutions have $5.97B invested in Herbalife in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 54 increasing their positions, 83 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 21

23% more capital invested

Capital invested by funds: $4.84B → $5.97B (+$1.12B)

10% more funds holding

Funds holding: 196215 (+19)

0.4% more ownership

Funds ownership: 84.7%85.11% (+0.4%)

30% less funds holding in top 10

Funds holding in top 10: 107 (-3)

35% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 83

53% less call options, than puts

Call options by funds: $90.4M | Put options by funds: $191M

Holders
215
Holders Change
+19
Holders Change %
+9.69%
% of All Funds
4.24%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.14%
New
46
Increased
54
Reduced
83
Closed
21
Calls
$90.4M
Puts
$191M
Net Calls
-$100M
Net Calls Change
-$50.8M
Name Holding Trade Value Shares
Change
Change in
Stake
IC
1
Icahn Carl
Florida
$1.68B
Capital Research Global Investors
2
Capital Research Global Investors
California
$884M +$458K +10,565 +0.1%
DVI
3
Deccan Value Investors
Connecticut
$497M -$59.6M -1,375,966 -12%
Vanguard Group
4
Vanguard Group
Pennsylvania
$461M -$15.5M -356,765 -4%
Renaissance Technologies
5
Renaissance Technologies
New York
$408M +$19M +439,563 +5%
BlackRock
6
BlackRock
New York
$214M -$18.5M -426,837 -9%
LPC
7
Lone Pine Capital
Connecticut
$186M +$77.6M +1,791,049 +85%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$147M -$45.5M -1,049,829 -25%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$93.4M +$10.7M +247,864 +14%
State Street
10
State Street
Massachusetts
$86.2M +$3.46M +79,791 +5%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$85.1M -$11.7M -269,531 -13%
ROIC
12
Route One Investment Company
California
$81M -$65.5M -1,513,000 -47%
BCM
13
Bronte Capital Management
Australia
$72.9M +$2.26M +52,075 +4%
APG Asset Management
14
APG Asset Management
Netherlands
$66M -$33.9M -781,722 -33%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$64.6M +$176K +4,059 +0.3%
Norges Bank
16
Norges Bank
Norway
$59M
CIP
17
CAS Investment Partners
Connecticut
$56.4M +$2.32M +53,626 +5%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$47.8M +$120K +2,761 +0.3%
Deutsche Bank
19
Deutsche Bank
Germany
$47.2M +$2.39M +55,078 +6%
ACB
20
Aristotle Capital Boston
Massachusetts
$45.3M +$853K +19,700 +2%
Millennium Management
21
Millennium Management
New York
$34.8M +$25.4M +587,087 +410%
CCM
22
Candlestick Capital Management
Connecticut
$32.4M +$29.5M +680,000 New
Northern Trust
23
Northern Trust
Illinois
$24.6M -$1.87M -43,258 -8%
Barclays
24
Barclays
United Kingdom
$23.6M +$16.7M +386,076 +351%
Charles Schwab
25
Charles Schwab
California
$22.7M -$170K -3,935 -0.8%

HLF Hedge Fund Activity: Q4 2019 in Review

215 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Herbalife (HLF) for Q4 2019, worth a combined $5.97B — up 23% from $4.84B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HLF positions and 21 closed out — a net gain of 25 holders — while 54 added to existing stakes and 83 trimmed.

The largest buyer was Lone Pine Capital, adding an estimated $77.6M. The largest seller was Route One Investment Company, cutting an estimated $65.5M.

  • 215 institutional investors held Herbalife (HLF) as of Q4 2019, up from 196 in Q3 2019.
  • Funds reported $5.97B of Herbalife stock for Q4 2019, up 23% quarter-over-quarter.
  • 46 funds opened new Herbalife positions in Q4 2019 and 21 closed out, a net change of +25 holders.
  • The largest Herbalife buyer in Q4 2019 was Lone Pine Capital, an estimated $77.6M added.
  • The largest Herbalife seller in Q4 2019 was Route One Investment Company, an estimated $65.5M sold.

Based on aggregated 13F filings for Q4 2019.